McKay Ian D H, Voss Logan J, Sleigh James W, Barnard John P, Johannsen Ewa K
Department of Anaesthesia, Waikato Hospital, New Zealand.
Anesth Analg. 2006 Jan;102(1):91-7. doi: 10.1213/01.ane.0000184825.65124.24.
Spectral entropy is a new electroencephalogram (EEG)-derived parameter that may be used to model the pharmacokinetic-pharmacodynamic (PKPD) effects of general anesthetics. In the present study we sought to derive a PKPD model of the relationship between sevoflurane concentration and spectral entropy of the EEG. We collected spectral entropy data during increasing and decreasing sevoflurane anesthesia from 20 patients. The first cycle consisted of induction and lightening phases with no supplemental medications. An effect-site compartment and inhibitory E(max) model described the relation between sevoflurane concentration and spectral entropy. PKPD parameters were derived from the full cycle and separately from the increasing and decreasing stages. The second anesthetic cycle consisted of a redeepening phase only and included airway manipulation and routinely administered adjunctives. PKPD data obtained from the first cycle were used to predict second cycle entropy changes. There was a consistent relationship between effect-site sevoflurane concentration and spectral entropy (median absolute weighted residual = 11.6%). For complete first-cycle response entropy (mean +/- sd): T1/2 K(eo) = 2.4 +/- 1.5 min, gamma = 5.9 +/- 2.3, EC50 = 1.7 +/- 0.3. We found significant differences between gamma values when the sevoflurane concentration was increasing (61.1 +/- 55.2) compared with the decreasing part of the cycle (5.7 +/- 2.8). Above an effect-site concentration of 3%, spectral entropy of the EEG is unresponsive to further increases in sevoflurane concentration. The effect-compartment inhibitory E(max) model accurately describes the relation between sevoflurane concentration and spectral entropy of the EEG. Spectral entropy decreases with increasing sevoflurane concentrations up to 3%. The steepness of the dose-response curve varies between phases of increasing and decreasing anesthetic concentrations.
频谱熵是一种新的从脑电图(EEG)得出的参数,可用于模拟全身麻醉药的药代动力学-药效学(PKPD)效应。在本研究中,我们试图推导七氟醚浓度与EEG频谱熵之间关系的PKPD模型。我们收集了20例患者在七氟醚麻醉浓度增加和降低过程中的频谱熵数据。第一个周期包括诱导期和加深期,未使用辅助药物。一个效应室房室模型和抑制性E(max)模型描述了七氟醚浓度与频谱熵之间的关系。PKPD参数从整个周期以及分别从浓度增加和降低阶段得出。第二个麻醉周期仅包括再次加深期,包括气道操作和常规使用的辅助药物。从第一个周期获得的PKPD数据用于预测第二个周期的熵变化。效应室七氟醚浓度与频谱熵之间存在一致关系(中位绝对加权残差 = 11.6%)。对于完整的第一个周期反应熵(均值±标准差):T1/2 K(eo) = 2.4 ± 1.5分钟,γ = 5.9 ± 2.3,EC50 = 1.7 ± 0.3。我们发现,七氟醚浓度增加时的γ值(61.1 ± 55.2)与周期中浓度降低部分的γ值(5.7 ± 2.8)之间存在显著差异。当效应室浓度高于3%时,EEG的频谱熵对七氟醚浓度的进一步增加无反应。效应室抑制性E(max)模型准确描述了七氟醚浓度与EEG频谱熵之间的关系。频谱熵随七氟醚浓度增加至3%而降低。剂量反应曲线的斜率在麻醉浓度增加和降低阶段有所不同。